These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 19521310)

  • 1. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
    Riaz A; Lewandowski RJ; Kulik L; Salem R
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yttrium-90 radioembolization in the management of liver malignancies.
    Riaz A; Kulik LM; Mulcahy MF; Lewandowski RJ; Salem R
    Semin Oncol; 2010 Apr; 37(2):94-101. PubMed ID: 20494701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors.
    Van De Wiele C; Defreyne L; Peeters M; Lambert B
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):317-24. PubMed ID: 19521311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review.
    Riaz A; Lewandowski RJ; Kulik LM; Mulcahy MF; Sato KT; Ryu RK; Omary RA; Salem R
    J Vasc Interv Radiol; 2009 Sep; 20(9):1121-30; quiz 1131. PubMed ID: 19640737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
    Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
    Salem R; Hunter RD
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S83-8. PubMed ID: 16979447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsphere radioembolization of liver malignancies: current developments.
    Bult W; Vente MA; Zonnenberg BA; Van Het Schip AD; Nijsen JF
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):325-35. PubMed ID: 19521312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
    Allison C
    Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
    Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
    Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
    Dawson LA
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
    [No Abstract]   [Full Text] [Related]  

  • 12. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
    Herzer K; Müller S; Antoch G; Hilgard P
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
    Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
    Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
    Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
    Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
    Salem R; Lewandowski RJ; Atassi B; Gordon SC; Gates VL; Barakat O; Sergie Z; Wong CY; Thurston KG
    J Vasc Interv Radiol; 2005 Dec; 16(12):1627-39. PubMed ID: 16371529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
    Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yttrium-90 radioembolization for the treatment of primary and metastatic liver tumors.
    Sato KT
    Semin Roentgenol; 2011 Apr; 46(2):159-65. PubMed ID: 21338841
    [No Abstract]   [Full Text] [Related]  

  • 18. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.
    Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN
    Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report.
    Kennedy A; Coldwell D; Sangro B; Wasan H; Salem R
    Am J Clin Oncol; 2012 Feb; 35(1):81-90. PubMed ID: 20938320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.